Strategic Clinical Sourcing Managing Costs and CROs

We are sorry but this premium report expired!

This market research was withdrawn from our website upon request of the publisher.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 46 pages

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Patient Perspectives - Patient Reported Outcomes Drive Drug Development, ...

Industries: Drug Discovery and Development | Countries: United States

Drug Discovery and Development Industry: Evotec Aktiengesellschaft - Product Pipeline Review - H2 2011

Drug Discovery and Development Industry: Evotec Aktiengesellschaft - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 195 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Evotec Aktiengesellschaft's corporate website, SEC ...

Industries: Drug Discovery and Development | Countries: United States

Choledocholithiasis Global Clinical Trials Review, H1, 2012

Choledocholithiasis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 54 pages

Choledocholithiasis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Choledocholithiasis Global Clinical Trials Review, H1, 2012" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 74 pages

Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2012" provides data on the Eosinophilic Esophagitis clinical trial scenario. This report provides elemental information and data ...

Industries: Drug Discovery and Development | Countries: World, United States

Fistula Global Clinical Trials Review, H1, 2012

Fistula Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 73 pages

Fistula Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Fistula Global Clinical Trials Review, H1, 2012" provides data on the Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fistula. It includes ...

Industries: Drug Discovery and Development | Countries: World

Lyme Disease Global Clinical Trials Review, H1, 2012

Lyme Disease Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 52 pages

Lyme Disease Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Lyme Disease Global Clinical Trials Review, H1, 2012" provides data on the Lyme Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lyme ...

Industries: Drug Discovery and Development | Countries: World

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 99 pages

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World, United States

Cholelithiasis Global Clinical Trials Review, H1, 2012

Cholelithiasis Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 70 pages

Cholelithiasis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Cholelithiasis Global Clinical Trials Review, H1, 2012" provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012

  • $ 1 000
  • Industry report
  • by Global Data
  • May 2012
  • 122 pages

Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, ?Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012" provides data on the Coronary Artery Disease (CAD) clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

The Pharmaceutical Industry Sourcing Landscape In 2011: Pharmaceutical Outsourcing Expands To Include Core Services

The Pharmaceutical Industry Sourcing Landscape In 2011: Pharmaceutical Outsourcing Expands To Include Core Services

  • $ 666
  • Industry report
  • by ValueNotes Database Pvt. Ltd.
  • May 2012

Executive Summary The pharmaceutical industry provides essential support to the healthcare system by innovating, manufacturing, marketing and supplying drugs. Over the last few years, the most prolific change in the industry has been the expansion of focus, from primarily research and development to ...

Industries: Drug Discovery and Development

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 618 48 97

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.